ARA-290 20 mg

ARA 290 Peptide — Erythropoietin-Derived Research Peptide (UK Supply)

ARA 290 is a high-purity, research-grade peptide derived from erythropoietin, widely studied in laboratory settings for its potential role in cellular protection, anti-inflammatory signalling, and tissue repair mechanisms. In UK research environments, it is used in controlled in-vitro and ex-vivo models to investigate immune modulation, cellular stress responses, and tissue regeneration pathways.

Supplied as a lyophilized peptide powder, ARA 290 is designed for stability, consistency, and reliable handling, supporting reproducible results across advanced biomedical and cellular research applications.

Key Facts About ARA 290

Research Uses

ARA 290 is commonly applied in UK laboratory research for:

• Anti-inflammatory signalling pathway investigations
• Tissue repair and regeneration studies
• Cellular communication and immune modulation research
• In-vitro models of cellular stress and recovery mechanisms
• Comparative analysis of peptide-mediated biological responses

Advantages for Laboratory Research

• High-purity formulation supports consistent, reproducible outcomes
• Stable lyophilized format suitable for long-term research storage
• Compatible with a wide range of cellular and tissue research models
• Supports detailed investigation of immune and repair pathways
• Reliable performance in controlled experimental environments

Why Choose ARA 290 in the UK?

ARA 290 is selected by researchers for its relevance in studying cellular protection mechanisms and inflammatory response pathways. Its defined peptide structure allows for controlled experimentation in tissue repair and immune modulation research under strict laboratory conditions.

In UK scientific settings, it is valued as a dependable tool for exploring erythropoietin-derived signalling pathways and cellular recovery processes.